APO Research
Talk to an analyst

APO RESEARCH · REPORT

DNA Biochip

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global DNA Biochip Market Outlook and Growth Opportunities 2026

3 May 2026199 pages

Choose your research edition.

Industry ResearchDNA Biochip Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal DNA Biochip Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal DNA Biochip Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DNA Biochip Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal DNA Biochip Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global DNA Biochip market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for DNA Biochip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for DNA Biochip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for DNA Biochip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the DNA Biochip market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the DNA Biochip market include Illumnia, Affymetrix, Agilent Technologies, Roche NimbleGen, Sengenics, Arrayit, Applied Microarrays, Biometrix Technology and Savyon Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global DNA Biochip market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of DNA Biochip and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents DNA Biochip sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the DNA Biochip market size, projected growth trends, production technologies, key applications, and end-use industries.

DNA Biochip Segment by Company

Illumnia

Affymetrix

Agilent Technologies

Roche NimbleGen

Sengenics

Arrayit

Applied Microarrays

Biometrix Technology

Savyon Diagnostics

Scienion AG

WaferGen

DNA Biochip Segment by Type

Oligonucleotide DNA Chip

Complementary DNA Chip

DNA Biochip Segment by Application

Gene Expression

Genotyping

Others

DNA Biochip Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global DNA Biochip status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions DNA Biochip market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify DNA Biochip significant trends, drivers, influence factors in global and regions.

6. To analyze DNA Biochip competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Biochip market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DNA Biochip and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Biochip.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the DNA Biochip market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global DNA Biochip industry.

Chapter 3: Detailed analysis of DNA Biochip manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of DNA Biochip in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of DNA Biochip in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. DNA Biochip Industry Trends Table 2. DNA Biochip Industry Drivers Table 3. DNA Biochip Industry Opportunities and Challenges Table 4. DNA Biochip Industry Restraints Table 5. Global DNA Biochip Revenue by Company (US$ Million) & (2021-2026) Table 6. Global DNA Biochip Revenue Share by Company (2021-2026) Table 7. Global DNA Biochip Sales Volume by Company (k units) & (2021-2026) Table 8. Global DNA Biochip Sales Volume Share by Company (2021-2026) Table 9. Global DNA Biochip Average Price (USD/unit) of Company (2021-2026) Table 10. Global DNA Biochip Company Ranking, (2024-2026) & (USD Million) Table 11. Global DNA Biochip Key Company Manufacturing Base & Headquarters Table 12. Global DNA Biochip Company, Product Type & Application Table 13. Global DNA Biochip Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global DNA Biochip by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oligonucleotide DNA Chip Table 18. Significant Companies of Complementary DNA Chip Table 19. Global DNA Biochip Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global DNA Biochip Sales Volume by Type (2021-2026) & (k units) Table 21. Global DNA Biochip Sales Volume by Type (2027-2032) & (k units) Table 22. Global DNA Biochip Sales Volume Share by Type (2021-2026) Table 23. Global DNA Biochip Sales Volume Share by Type (2027-2032) Table 24. Global DNA Biochip Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global DNA Biochip Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global DNA Biochip Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global DNA Biochip Sales Value Share by Type (2021-2026) Table 28. Global DNA Biochip Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Gene Expression Table 30. Significant Companies of Genotyping Table 31. Significant Companies of Others Table 32. Global DNA Biochip Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global DNA Biochip Sales Volume by Application (2021-2026) & (k units) Table 34. Global DNA Biochip Sales Volume by Application (2027-2032) & (k units) Table 35. Global DNA Biochip Sales Volume Share by Application (2021-2026) Table 36. Global DNA Biochip Sales Volume Share by Application (2027-2032) Table 37. Global DNA Biochip Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global DNA Biochip Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global DNA Biochip Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global DNA Biochip Sales Value Share by Application (2021-2026) Table 41. Global DNA Biochip Sales Value Share by Application (2027-2032) Table 42. Global DNA Biochip Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global DNA Biochip Sales by Region (2021-2026) & (k units) Table 44. Global DNA Biochip Sales Market Share by Region (2021-2026) Table 45. Global DNA Biochip Sales by Region (2027-2032) & (k units) Table 46. Global DNA Biochip Sales Market Share by Region (2027-2032) Table 47. Global DNA Biochip Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global DNA Biochip Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global DNA Biochip Sales Value Share by Region (2021-2026) Table 50. Global DNA Biochip Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global DNA Biochip Sales Value Share by Region (2027-2032) Table 52. Global DNA Biochip Market Average Price (USD/unit) by Region (2021-2026) Table 53. Global DNA Biochip Market Average Price (USD/unit) by Region (2027-2032) Table 54. Global DNA Biochip Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global DNA Biochip Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global DNA Biochip Sales by Country (2021-2026) & (k units) Table 57. Global DNA Biochip Sales Market Share by Country (2021-2026) Table 58. Global DNA Biochip Sales by Country (2027-2032) & (k units) Table 59. Global DNA Biochip Sales Market Share by Country (2027-2032) Table 60. Global DNA Biochip Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global DNA Biochip Sales Value Market Share by Country (2021-2026) Table 62. Global DNA Biochip Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global DNA Biochip Sales Value Market Share by Country (2027-2032) Table 64. Illumnia Company Information Table 65. Illumnia Business Overview Table 66. Illumnia DNA Biochip Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. Illumnia DNA Biochip Product Portfolio Table 68. Illumnia Recent Development Table 69. Affymetrix Company Information Table 70. Affymetrix Business Overview Table 71. Affymetrix DNA Biochip Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. Affymetrix DNA Biochip Product Portfolio Table 73. Affymetrix Recent Development Table 74. Agilent Technologies Company Information Table 75. Agilent Technologies Business Overview Table 76. Agilent Technologies DNA Biochip Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Agilent Technologies DNA Biochip Product Portfolio Table 78. Agilent Technologies Recent Development Table 79. Roche NimbleGen Company Information Table 80. Roche NimbleGen Business Overview Table 81. Roche NimbleGen DNA Biochip Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Roche NimbleGen DNA Biochip Product Portfolio Table 83. Roche NimbleGen Recent Development Table 84. Sengenics Company Information Table 85. Sengenics Business Overview Table 86. Sengenics DNA Biochip Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Sengenics DNA Biochip Product Portfolio Table 88. Sengenics Recent Development Table 89. Arrayit Company Information Table 90. Arrayit Business Overview Table 91. Arrayit DNA Biochip Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Arrayit DNA Biochip Product Portfolio Table 93. Arrayit Recent Development Table 94. Applied Microarrays Company Information Table 95. Applied Microarrays Business Overview Table 96. Applied Microarrays DNA Biochip Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Applied Microarrays DNA Biochip Product Portfolio Table 98. Applied Microarrays Recent Development Table 99. Biometrix Technology Company Information Table 100. Biometrix Technology Business Overview Table 101. Biometrix Technology DNA Biochip Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Biometrix Technology DNA Biochip Product Portfolio Table 103. Biometrix Technology Recent Development Table 104. Savyon Diagnostics Company Information Table 105. Savyon Diagnostics Business Overview Table 106. Savyon Diagnostics DNA Biochip Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Savyon Diagnostics DNA Biochip Product Portfolio Table 108. Savyon Diagnostics Recent Development Table 109. Scienion AG Company Information Table 110. Scienion AG Business Overview Table 111. Scienion AG DNA Biochip Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Scienion AG DNA Biochip Product Portfolio Table 113. Scienion AG Recent Development Table 114. WaferGen Company Information Table 115. WaferGen Business Overview Table 116. WaferGen DNA Biochip Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. WaferGen DNA Biochip Product Portfolio Table 118. WaferGen Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. DNA Biochip Distributors List Table 122. DNA Biochip Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. DNA Biochip Product Image Figure 2. Global DNA Biochip Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DNA Biochip Sales Value (2021-2032) & (US$ Million) Figure 4. Global DNA Biochip Sales (2021-2032) & (k units) Figure 5. Global DNA Biochip Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global DNA Biochip Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oligonucleotide DNA Chip Image Figure 10. Complementary DNA Chip Image Figure 11. Global DNA Biochip Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global DNA Biochip Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global DNA Biochip Sales Volume Share by Type (2021-2032) Figure 14. Global DNA Biochip Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global DNA Biochip Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global DNA Biochip Sales Value Share by Type (2021-2032) Figure 17. Gene Expression Image Figure 18. Genotyping Image Figure 19. Others Image Figure 20. Global DNA Biochip Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global DNA Biochip Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global DNA Biochip Sales Volume Share by Application (2021-2032) Figure 23. Global DNA Biochip Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global DNA Biochip Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global DNA Biochip Sales Value Share by Application (2021-2032) Figure 26. Global DNA Biochip Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global DNA Biochip Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global DNA Biochip Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global DNA Biochip Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America DNA Biochip Sales Value (2021-2032) & (US$ Million) Figure 31. North America DNA Biochip Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe DNA Biochip Sales Value (2021-2032) & (US$ Million) Figure 33. Europe DNA Biochip Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific DNA Biochip Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific DNA Biochip Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America DNA Biochip Sales Value (2021-2032) & (US$ Million) Figure 37. South America DNA Biochip Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa DNA Biochip Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa DNA Biochip Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt DNA Biochip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt DNA Biochip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt DNA Biochip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. DNA Biochip Value Chain Figure 125. Manufacturing Cost Structure Figure 126. DNA Biochip Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Oligonucleotide DNA Chip
  • Complementary DNA Chip
Applications
  • Gene Expression
  • Genotyping
  • Others
Companies covered
  • Illumnia
  • Affymetrix
  • Agilent Technologies
  • Roche NimbleGen
  • Sengenics
  • Arrayit
  • Applied Microarrays
  • Biometrix Technology
  • Savyon Diagnostics
  • Scienion AG
  • WaferGen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global DNA Biochip Sales Value (2021-2032)
  4. 1.2.2 Global DNA Biochip Sales Volume (2021-2032)
  5. 1.2.3 Global DNA Biochip Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 DNA Biochip Market Dynamics
  1. 2.1 DNA Biochip Industry Trends
  2. 2.2 DNA Biochip Industry Drivers
  3. 2.3 DNA Biochip Industry Opportunities and Challenges
  4. 2.4 DNA Biochip Industry Restraints
3 DNA Biochip Market by Company
  1. 3.1 Global DNA Biochip Company Revenue Ranking in 2025
  2. 3.2 Global DNA Biochip Revenue by Company (2021-2026)
  3. 3.3 Global DNA Biochip Sales Volume by Company (2021-2026)
  4. 3.4 Global DNA Biochip Average Price by Company (2021-2026)
  5. 3.5 Global DNA Biochip Company Ranking (2024-2026)
  6. 3.6 Global DNA Biochip Company Manufacturing Base and Headquarters
  7. 3.7 Global DNA Biochip Company Product Type and Application
  8. 3.8 Global DNA Biochip Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global DNA Biochip Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 DNA Biochip Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 DNA Biochip Market by Type
  1. 4.1 DNA Biochip Type Introduction
  2. 4.1.1 Oligonucleotide DNA Chip
  3. 4.1.2 Complementary DNA Chip
  4. 4.2 Global DNA Biochip Sales Volume by Type
  5. 4.2.1 Global DNA Biochip Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global DNA Biochip Sales Volume by Type (2021-2032)
  7. 4.2.3 Global DNA Biochip Sales Volume Share by Type (2021-2032)
  8. 4.3 Global DNA Biochip Sales Value by Type
  9. 4.3.1 Global DNA Biochip Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global DNA Biochip Sales Value by Type (2021-2032)
  11. 4.3.3 Global DNA Biochip Sales Value Share by Type (2021-2032)
5 DNA Biochip Market by Application
  1. 5.1 DNA Biochip Application Introduction
  2. 5.1.1 Gene Expression
  3. 5.1.2 Genotyping
  4. 5.1.3 Others
  5. 5.2 Global DNA Biochip Sales Volume by Application
  6. 5.2.1 Global DNA Biochip Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global DNA Biochip Sales Volume by Application (2021-2032)
  8. 5.2.3 Global DNA Biochip Sales Volume Share by Application (2021-2032)
  9. 5.3 Global DNA Biochip Sales Value by Application
  10. 5.3.1 Global DNA Biochip Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global DNA Biochip Sales Value by Application (2021-2032)
  12. 5.3.3 Global DNA Biochip Sales Value Share by Application (2021-2032)
6 DNA Biochip Regional Sales and Value Analysis
  1. 6.1 Global DNA Biochip Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global DNA Biochip Sales by Region (2021-2032)
  3. 6.2.1 Global DNA Biochip Sales by Region: 2021-2026
  4. 6.2.2 Global DNA Biochip Sales by Region (2027-2032)
  5. 6.3 Global DNA Biochip Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global DNA Biochip Sales Value by Region (2021-2032)
  7. 6.4.1 Global DNA Biochip Sales Value by Region: 2021-2026
  8. 6.4.2 Global DNA Biochip Sales Value by Region (2027-2032)
  9. 6.5 Global DNA Biochip Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America DNA Biochip Sales Value (2021-2032)
  12. 6.6.2 North America DNA Biochip Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe DNA Biochip Sales Value (2021-2032)
  15. 6.7.2 Europe DNA Biochip Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific DNA Biochip Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific DNA Biochip Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America DNA Biochip Sales Value (2021-2032)
  21. 6.9.2 South America DNA Biochip Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa DNA Biochip Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa DNA Biochip Sales Value Share by Country, 2025 VS 2032
7 DNA Biochip Country-level Sales and Value Analysis
  1. 7.1 Global DNA Biochip Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global DNA Biochip Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global DNA Biochip Sales by Country (2021-2032)
  4. 7.3.1 Global DNA Biochip Sales by Country (2021-2026)
  5. 7.3.2 Global DNA Biochip Sales by Country (2027-2032)
  6. 7.4 Global DNA Biochip Sales Value by Country (2021-2032)
  7. 7.4.1 Global DNA Biochip Sales Value by Country (2021-2026)
  8. 7.4.2 Global DNA Biochip Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA DNA Biochip Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA DNA Biochip Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA DNA Biochip Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada DNA Biochip Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada DNA Biochip Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada DNA Biochip Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico DNA Biochip Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico DNA Biochip Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico DNA Biochip Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany DNA Biochip Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany DNA Biochip Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany DNA Biochip Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France DNA Biochip Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France DNA Biochip Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France DNA Biochip Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. DNA Biochip Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. DNA Biochip Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. DNA Biochip Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy DNA Biochip Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy DNA Biochip Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy DNA Biochip Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain DNA Biochip Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain DNA Biochip Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain DNA Biochip Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia DNA Biochip Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia DNA Biochip Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia DNA Biochip Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands DNA Biochip Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands DNA Biochip Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands DNA Biochip Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries DNA Biochip Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries DNA Biochip Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries DNA Biochip Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China DNA Biochip Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China DNA Biochip Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China DNA Biochip Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan DNA Biochip Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan DNA Biochip Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan DNA Biochip Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea DNA Biochip Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea DNA Biochip Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea DNA Biochip Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India DNA Biochip Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India DNA Biochip Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India DNA Biochip Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia DNA Biochip Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia DNA Biochip Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia DNA Biochip Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia DNA Biochip Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia DNA Biochip Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia DNA Biochip Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil DNA Biochip Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil DNA Biochip Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil DNA Biochip Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina DNA Biochip Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina DNA Biochip Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina DNA Biochip Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile DNA Biochip Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile DNA Biochip Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile DNA Biochip Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia DNA Biochip Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia DNA Biochip Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia DNA Biochip Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru DNA Biochip Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru DNA Biochip Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru DNA Biochip Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia DNA Biochip Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia DNA Biochip Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia DNA Biochip Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel DNA Biochip Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel DNA Biochip Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel DNA Biochip Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE DNA Biochip Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE DNA Biochip Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE DNA Biochip Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey DNA Biochip Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey DNA Biochip Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey DNA Biochip Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran DNA Biochip Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran DNA Biochip Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran DNA Biochip Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt DNA Biochip Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt DNA Biochip Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt DNA Biochip Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Illumnia
  2. 8.1.1 Illumnia Company Information
  3. 8.1.2 Illumnia Business Overview
  4. 8.1.3 Illumnia DNA Biochip Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Illumnia DNA Biochip Product Portfolio
  6. 8.1.5 Illumnia Recent Developments
  7. 8.2 Affymetrix
  8. 8.2.1 Affymetrix Company Information
  9. 8.2.2 Affymetrix Business Overview
  10. 8.2.3 Affymetrix DNA Biochip Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Affymetrix DNA Biochip Product Portfolio
  12. 8.2.5 Affymetrix Recent Developments
  13. 8.3 Agilent Technologies
  14. 8.3.1 Agilent Technologies Company Information
  15. 8.3.2 Agilent Technologies Business Overview
  16. 8.3.3 Agilent Technologies DNA Biochip Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Agilent Technologies DNA Biochip Product Portfolio
  18. 8.3.5 Agilent Technologies Recent Developments
  19. 8.4 Roche NimbleGen
  20. 8.4.1 Roche NimbleGen Company Information
  21. 8.4.2 Roche NimbleGen Business Overview
  22. 8.4.3 Roche NimbleGen DNA Biochip Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Roche NimbleGen DNA Biochip Product Portfolio
  24. 8.4.5 Roche NimbleGen Recent Developments
  25. 8.5 Sengenics
  26. 8.5.1 Sengenics Company Information
  27. 8.5.2 Sengenics Business Overview
  28. 8.5.3 Sengenics DNA Biochip Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sengenics DNA Biochip Product Portfolio
  30. 8.5.5 Sengenics Recent Developments
  31. 8.6 Arrayit
  32. 8.6.1 Arrayit Company Information
  33. 8.6.2 Arrayit Business Overview
  34. 8.6.3 Arrayit DNA Biochip Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Arrayit DNA Biochip Product Portfolio
  36. 8.6.5 Arrayit Recent Developments
  37. 8.7 Applied Microarrays
  38. 8.7.1 Applied Microarrays Company Information
  39. 8.7.2 Applied Microarrays Business Overview
  40. 8.7.3 Applied Microarrays DNA Biochip Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Applied Microarrays DNA Biochip Product Portfolio
  42. 8.7.5 Applied Microarrays Recent Developments
  43. 8.8 Biometrix Technology
  44. 8.8.1 Biometrix Technology Company Information
  45. 8.8.2 Biometrix Technology Business Overview
  46. 8.8.3 Biometrix Technology DNA Biochip Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Biometrix Technology DNA Biochip Product Portfolio
  48. 8.8.5 Biometrix Technology Recent Developments
  49. 8.9 Savyon Diagnostics
  50. 8.9.1 Savyon Diagnostics Company Information
  51. 8.9.2 Savyon Diagnostics Business Overview
  52. 8.9.3 Savyon Diagnostics DNA Biochip Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Savyon Diagnostics DNA Biochip Product Portfolio
  54. 8.9.5 Savyon Diagnostics Recent Developments
  55. 8.10 Scienion AG
  56. 8.10.1 Scienion AG Company Information
  57. 8.10.2 Scienion AG Business Overview
  58. 8.10.3 Scienion AG DNA Biochip Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Scienion AG DNA Biochip Product Portfolio
  60. 8.10.5 Scienion AG Recent Developments
  61. 8.11 WaferGen
  62. 8.11.1 WaferGen Company Information
  63. 8.11.2 WaferGen Business Overview
  64. 8.11.3 WaferGen DNA Biochip Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 WaferGen DNA Biochip Product Portfolio
  66. 8.11.5 WaferGen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 DNA Biochip Value Chain Analysis
  2. 9.1.1 DNA Biochip Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 DNA Biochip Sales Mode & Process
  6. 9.2 DNA Biochip Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 DNA Biochip Distributors
  9. 9.2.3 DNA Biochip Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst